Large Cap · Consumer Defensive · Household & Personal Products
Large Cap · Consumer Defensive · Household & Personal Products
Get the AI take on CLX
Track it to unlock the price chart, verdict and what could change it.
Free to track. No card required.
Overall score
52/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Lowest
$77
Median target
$100
Current price
$107.62
Highest
$155
Forward P/E
Favorable · 23% below avg
18.20x
Price / sales
Strong · Priced modestly against the revenue it brings in
1.90x
Price / FCF
Reasonable · Priced a bit rich against its cash flow
31.56x
EV / EBITDA
Reasonable · Operating earnings make this price a stretch but plausible
16.00x
ROIC
Reasonable · A middling return on the capital it puts to work
14.9%
ROE
Favorable · 4163.2% - strong capital efficiency
163.8%
Debt / equity
Rich · Carrying more debt than equity can comfortably absorb
22.21x
Current ratio
Weak · Not enough on hand to cover near-term bills
0.66x
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $12.78B | 22.0 | -5.4% | 52 | |
| $7.36B | 125.8 | +82.9% | 72 | |
| $4.62B | 18.9 | +16.7% | 72 | |
| $10.58B | 18.0 | +14.8% | 70 | |
| $5.18B | 16.9 | +17.9% | 68 |